ArticleBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2023

Retention Rate and Safety of Biologic and Targeted Synthetic DMARDs in Patients with RA-Associated Interstitial Lung Disease: A KOBIO Registry Study.

Sun-Kyung Lee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.